Skip to content

Clinical trials

Phase 1 Heart Failure trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 1 Country / region: United States Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20054
20062
20075
20087
20094
20103
20113
20125
20132
20142
20155
20165
20178
20186
20195
20205
20213
20228
20233
20245
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Recruiting14
Terminated8
Unknown status6
Withdrawn5
Suspended1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic7
Yale University7
Bristol-Myers Squibb5
AstraZeneca3
Acorda Therapeutics2
Amgen2
Bioheart, Inc.2
Eli Lilly and Company2
Emory University2
M.D. Anderson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure104
Cardiomyopathies12
Cardiovascular Diseases9
Myocardial Infarction8
Heart Diseases6
Cardiomyopathy, Dilated4
Coronary Artery Disease4
Heart Failure, Diastolic4
Hypertension4
Diabetes Mellitus, Type 23

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.